ABDX — Abingdon Health PlcHealthcare · Diagnostics & ResearchLSE
GBp 30.1M
Mkt Cap
GBp 34.1M
Ent. Value
GBp 12.00
52W GBp 5 – GBp 11
GBp 30.1M
Mkt Cap
GBp 34.1M
Ent. Value
N/M
P/E TTM
—
PEG
-8.1×
P/FCF
4.0×
P/Book
2.2×
P/Sales
-14.3×
EV/EBITDA
-10.8×
EV/EBIT
-12.9×
EV/FCF
3.6×
EV/Sales
-15.2%
Earn Yld
-12.4%
FCF Yld
—
Div Yld
GBp 12.00
·
All values in British Pounds (GBP)
GBP
FY2025
FY2024
FY2023
FY2022
Revenue
8.43M
6.13M
4.04M
2.83M
YoY Growth
+37.4%
+51.7%
+42.7%
—
Gross Profit
3.74M
3.68M
2.08M
(3.59M)
Gross Margin
44.3%
60.0%
51.3%
-126.7%
R&D
—
—
—
—
SG&A
7.71M
5.31M
5.22M
6.64M
EBIT
(3.51M)
(1.37M)
(3.61M)
(12.01M)
EBIT Margin
-41.6%
-22.4%
-89.3%
-423.7%
D&A
608,000
426,000
688,000
1.64M
EBITDA
(2.80M)
(916,000)
(2.81M)
(19.89M)
EBITDA Margin
-33.2%
-14.9%
-69.5%
-701.5%
Net Income
(3.42M)
(1.27M)
(3.47M)
(21.26M)
Net Margin
-40.5%
-20.7%
-85.8%
-750.0%
EPS (diluted)
-£0.01
-£0.00
-£0.01
-£0.07
Shares (dil., M)
373
308
306
292
Company Brief
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is based in York, the United Kingdom.
CEODr. Christopher William HandEmployees129IPO Date2020-12-15CountryUnited KingdomWebsitewww.abingdonhealth.com
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturing, Product Sales, and Regulatory segments. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is based in York, the United Kingdom.
CEODr. Christopher William HandEmployees129IPO Date2020-12-15CountryUnited KingdomWebsitewww.abingdonhealth.com
